These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Search MEDLINE/PubMed


  • Title: [Heparin cofactor II and thrombophilic conditions].
    Author: Hudecek J, Hal'áková E, Ivanková J, Kubisz P.
    Journal: Vnitr Lek; 1997 May; 43(5):317-9. PubMed ID: 9601856.
    Abstract:
    Heparin co-factor II is in addition to antithrombin III another heparin dependent thrombin inhibitor. This glycoprotein blocks thrombin action not only in haemostasis but also in its other effects. Congenital deficiency of heparin co-factor II was found equally frequently among asymptomatic subjects and patients with thrombotic complications. Although its deficiency probably is not a serious risk factor of thromboembolic disease, it can promote its development in a significant way. The authors describe the case of a child with thrombotic complications and a congenital deficiency of heparin co-factor II.
    [Abstract] [Full Text] [Related] [New Search]